Carbamazepine
NDC 62135-867, Carbamazepine, suspension, from Chartwell RX, LLC.
- Product NDC
- 62135-867
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075714
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-867 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBAMAZEPINE200 mg/10mL
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-867-24 | 62135086724 | 2 TRAY in 1 BOX (62135-867-24) / 10 PACKAGE in 1 TRAY / 10 mL in 1 PACKAGE (62135-867-59) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8d5ace90-983b-48c4-baf1-b44f6af146de
Use it
Look up 62135-867 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-867 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-867. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.